TRVN Insider Trading
Insider Ownership Percentage: 2.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Trevena Share Price & Price History
Current Price: $1.22
Price Change: ▼ Price Decrease of -0.0025 (-0.20%)
As of 04/1/2025 02:32 PM ET
Trevena Insider Trading History
Trevena Institutional Trading History
Data available starting January 2016
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is based in Chesterbrook, Pennsylvania.
Read More on Trevena
Volume
405 shs
Average Volume
2,564 shs
Market Capitalization
$1.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.05